Association of Mandatory-Access Prescription Drug Monitoring Programs With Opioid Prescriptions Among Medicare Patients Treated by a Medical or Hematologic Oncologist.

Ilana Graetz Courtney R Yarbrough Xin Hu David H Howard

JAMA Oncol

Winship Cancer Center, School of Public Health, Department of Health Policy and Management, Rollins Emory University, Atlanta, Georgia.

Published: July 2020

This cohort study examines the association between prescription drug monitoring program mandates with and without a cancer exemption and the percent of oncologists’ patients with any opioid prescription covered by Medicare Part D.

Download full-text PDF	Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7206528	PMC
http://dx.doi.org/10.1001/jamaoncol.2020.0804	DOI Listing

Publication Analysis

Top Keywords

prescription drug

drug monitoring

association mandatory-access

mandatory-access prescription

monitoring programs

programs opioid

opioid prescriptions

prescriptions medicare

medicare patients

patients treated

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!